Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection
- PMID: 35590202
- DOI: 10.1016/j.medj.2021.09.005
Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection
Abstract
Liquid biopsy detection of residual cancer after therapy offers to transform oncology care. Nonetheless, in the residual cancer context, signals are sparse and are hindered by technical sequencing noise. Kurtz et al.1 introduce phased variant enrichment and detection sequencing (phasED-seq) to increase the circulating tumor DNA signal-to-noise ratio and detect minimal residual disease with unprecedented sensitivity.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interest D.L. is a co-founder of C2i Genomics and a member of its scientific advisory board.
Comment on
-
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.Nat Biotechnol. 2021 Dec;39(12):1537-1547. doi: 10.1038/s41587-021-00981-w. Epub 2021 Jul 22. Nat Biotechnol. 2021. PMID: 34294911 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources